Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1379158
PUBLISHER: IMARC | PRODUCT CODE: 1379158
Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global viral inactivation market size reached US$ 577.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,028.4 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2022-2028.
Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.
Viral Inactivation Market Trends:
Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application and end use.
Breakup by Product:
Reagents and Kits
Systems
Services
Breakup by Application:
Vaccines and Therapeutics
Stem Cell Products
Blood and Blood Products
Tissue and Tissue Products
Cellular and Gene Therapy
Breakup by End Use:
Pharmaceutical and Biotechnology Companies
CROs
Academic and Research Institutes
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.
Key Questions Answered in This Report:
- How has the global viral inactivation market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global viral inactivation market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global viral inactivation market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A4115
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Viral Inactivation Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Reagents and Kits
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Systems
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Vaccines and Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Stem Cell Products
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Blood and Blood Products
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Tissue and Tissue Products
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Cellular and Gene Therapy
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by End Use
- 8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 CROs
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Charles River Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Merck KGaA
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Parker Hannifin Corp
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Rad Source Technologies
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Sartorius AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 SGS SA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Terumo Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Texcell
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.9 Vironova AB
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 WuXi AppTec
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.1 Charles River Laboratories
Product Code: SR112023A4115
List of Figures
- Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
- Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2022
- Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2022
- Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2022
- Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2022
- Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2022
- Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
- Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
- Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2023-2028
- Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 6: Global: Viral Inactivation Market: Competitive Structure
- Table 7: Global: Viral Inactivation Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.